n/a
The present invention relates to systems and methods of use thereof for controlled fluid delivery in medical devices to provide safe and effective treatment.
Minimally invasive devices, such as catheters, are often employed for medical procedures, including those involving mapping, ablation, dilation, and the like. For example, a thermal diagnostic or treatment procedure may involve permanently and/or temporarily exchanging thermal energy with a targeted tissue region, such as creating a series of inter-connecting or otherwise substantially continuous lesions in order to electrically isolate tissue believed to be the source of an arrhythmia. An example of a thermal mechanism for diagnosis and treatment is a cryogenic device that uses the energy transfer derived from thermodynamic changes occurring in the flow of a cryogen therethrough to create a net transfer of heat flow from the target tissue to the device. The quality and magnitude of heat transfer is regulated in large part by the device configuration and control of the cryogen flow regime within the device.
Structurally, cooling can be achieved through injection of high pressure refrigerant through an orifice. Upon injection from the orifice, a refrigerant may undergo two primary thermodynamic changes: (i) expanding to low pressure and temperature through positive Joule-Thomson throttling, and (ii) undergoing a phase change from liquid to vapor, thereby absorbing heat of vaporization. The resultant flow of low temperature refrigerant through the device acts to absorb heat from the target tissue and thereby cool the tissue to the desired temperature.
The efficacy of a thermal exchange procedure may be substantially affected by the fluid flow through the device as well as the thermal conductivity between a device and the tissue site. To provide shorter treatment durations and increased efficacy for the particular treatment provided, it is desirable to optimize the heat transfer between the specific tissue to be treated and the cryogenic element or device. Such optimization may include providing accurate and precise fluid delivery through a selected device to achieve the desired thermal affect in the physiological location being treated. Such physiological locations often include numerous environmental factors that can constantly change, resulting in fluctuating thermal conditions arising between the tissue and the device. For example, blood or other body fluids passing through the vicinity of the thermal device can reduce the quality of thermal exchange with the targeted tissue, which can then necessitate additional “cooling power” or refrigerant flow in the case of cryogenic treatments in order to complete the desired treatment.
Accordingly, it is desirable to provide systems and methods of use thereof that provide accurate and precise control over fluid delivery to and through such devices in order to optimize the efficacy of the device in a physiological environment.
The present invention advantageously provides systems and methods of use thereof that provide accurate and precise control over fluid delivery to and through such devices in order to optimize the efficacy of the device in a physiological environment. In particular, a medical device is provided, including a catheter body defining a distal portion; a fluid delivery conduit defining an outlet in the distal portion of the catheter body, an elongate member movably disposed within at least a portion of the fluid delivery conduit to selectively obstruct a portion of the fluid delivery conduit to modulate fluid flow through the outlet. The medical device may define a fluid exhaust lumen within the catheter body, the fluid delivery conduit may define a tapered diameter, and/or the elongate member may be longitudinally movable with respect to the tapered diameter. The elongate member may include a plug movably positionable about the outlet, where the plug may include a tapered cross-section and/or be substantially spherical. The elongate member may be constructed from a shape memory material that transitions in response to a thermal and/or electrical load. The fluid delivery conduit may define a plurality of outlets in the distal portion, and the elongate member may be movable to selectively obstruct the plurality of outlets. The medical device may include a cryogenic fluid source in fluid communication with at least one of the fluid delivery conduit or elongate member.
A method of regulating fluid flow through a catheter is provided, including delivering a fluid to a fluid delivery conduit disposed within a portion of the catheter; and moving a rod within a portion of the fluid delivery conduit to at least partially obstruct a portion of the fluid delivery conduit to regulate fluid flowing therethrough. The fluid delivery conduit may define a tapered section, and moving the rod may include moving the rod with respect to the tapered section.
A medical device is provided, including a catheter body defining a distal portion; a fluid delivery conduit defining an outlet in the distal portion of the catheter body, and a deformation element within the catheter body, the deformation element controllably movable to deform a portion of the fluid delivery conduit. The deformation element may be movable substantially perpendicularly to the fluid delivery conduit to depress a portion of the fluid delivery conduit and/or may be rotatable about the fluid delivery conduit to depress a portion of the fluid delivery conduit.
A method of regulating fluid flow through a catheter is disclosed, including delivering a fluid to a first conduit disposed within a portion of the catheter; and mechanically deforming a portion of the first conduit to controllably regulate fluid flowing therethrough.
A method of controlling fluid delivery in a medical device is provided, including movably positioning a fluid delivery conduit within a delivery manifold in the medical device, the fluid delivery conduit defining a first plurality of openings and the delivery manifold defining a second plurality of openings; introducing a fluid into the fluid delivery conduit; moving the fluid delivery conduit to a first position where the first plurality of openings is substantially aligned with the second plurality of openings to direct fluid through the first and second plurality of openings; and moving the fluid delivery conduit to a second position where the second plurality of openings are substantially obstructed by the fluid delivery conduit, and at least one of the plurality of first openings is positioned outside the manifold such that fluid is directed through the at least one of the plurality of first openings. The second plurality of openings may be asymmetrically disposed about a longitudinal axis of the manifold, the fluid may include a cryogenic fluid, and/or the medical device may include a thermally-transmissive region proximate the delivery manifold, such as a balloon or an electrode.
A medical device is disclosed, including an elongate body defining a distal portion; and a unitary distal insert coupled to the distal portion, the distal insert defining: a first lumen extending therethrough, a second lumen coaxial with the first lumen, and a plurality of openings in fluid communication with the second lumen. The unitary distal insert may define a collar and the medical device may include one or more steering elements coupled to the collar. The medical device may include a thermally-transmissive region substantially enclosing the distal insert and/or a rod movably positionable with a portion of the first lumen.
A more complete understanding of the present invention, and the attendant advantages and features thereof, will be more readily understood by reference to the following detailed description when considered in conjunction with the accompanying drawings wherein:
The present invention advantageously provides systems and methods of use thereof that provide accurate and precise control over fluid delivery to and through such devices in order to optimize the efficacy of the device in a physiological environment. Referring now to the drawing figures in which like reference designations refer to like elements, an embodiment of a medical system constructed in accordance with principles of the present invention is shown in
Continuing to refer to
The medical device 12 may further include a fluid delivery conduit 22 traversing at least a portion of the elongate body 16 and distal portion 20. The delivery conduit 22 may be coupled to or otherwise extend from the proximal portion 18 of the elongate body 16. The fluid delivery conduit 22 may be flexible, constructed from a shape memory material (such as Nitinol), and/or include other controllably deformable materials that allow the fluid delivery conduit 22 to be manipulated for selective fluid flow control as described herein. The fluid delivery conduit 22 may define a lumen therein for the passage or delivery of a fluid from the proximal portion of the elongate body 16 and/or the control unit 14 to the distal portion 20 and/or treatment region of the medical device 12. The fluid delivery conduit 22 may further include one or more apertures or openings therein providing dispersion or directed ejection of fluid from the lumen to an environment exterior to the fluid delivery conduit 22.
The elongate body 16 may also define or otherwise include an exhaust lumen 24 in fluid communication with the distal portion 20, proximal portion 18, and/or control unit 14 to facilitate circulation or removal of fluid within the medical device 12. A guide wire lumen may also be disposed or otherwise included in the elongate body 16.
Now referring to
The medical device 12 may further include a thermally-transmissive region 46 at the distal portion 20 that provides for energy exchange between the medical device 10 and targeted tissue region. The thermally-transmissive region 46 may include, for example, a thermally- and/or electrically-conductive shell (as shown in
Referring now to
Referring now to
As shown in
Now referring to
Turning to
Fluid flow may further be controlled through the implementation of one or more rotational components disposed within or about the fluid flow path through the delivery conduit. For example, referring to
A rate or volume of fluid flowing through the medical device 12 may further be controlled through selective opening or closing of all or part of a plurality of openings or fluid dispersion points within the medical device 12o selectively control the amount, direction, location, size, and/or other characteristics of the dispersion area. In thermal treatment procedures, such fluid control provides the ability to directly control the resulting location, size, and other characteristics of the tissue treatment pattern. For example referring to
One or more of the fluid outlets 66 may also include a directional taper or angular orientation, as shown in
Aside from and/or in addition to providing selective fluid dispersion in a proximal-distal range, the medical device may also provide selective radial or rotational dispersion of the fluid either separately or in combination with the proximal-distal range to provide a variety of longitudinally and radially controllable dispersion patterns. For example, referring to
Turning now to
As shown in
Turning now to
Returning again to
The handle 94 may also include one or more actuation or control features that allow a user to control, deflect, steer, or otherwise manipulate a distal portion of the medical device from the proximal portion of the medical device. For example, the handle 94 may include one or more components such as a lever or knob 102 for manipulating the elongate body 16 and/or additional components of the medical device 12, such as the selectors, manifolds, or other fluid flow components described herein. Movement or operation of these components may be triggered or performed mechanically, electro-mechanically, and/or in conjunction with one or more sensors described herein to the provide a variety of predetermined configurations and/or fluid flow sequences or patterns. For example, a pull wire 104 with a proximal end and a distal end may have its distal end anchored to the elongate body 16 at or near the distal portion 20, such as the distal insert 26. The proximal end of the pull wire 94 may be anchored to an element such as a cam in communication with and responsive to the lever 102.
The medical device 12 may include an actuator element 106 that is movably coupled to the proximal portion of the elongate body 16 and/or the handle 94. The actuator element 106 may further be coupled to a proximal portion of the fluid delivery conduit 22, rod 50, 68, and/or selectors 76,86 such that manipulating the actuator element 106 in a longitudinal direction causes longitudinal manipulation of the attached component. The actuator element 106 may include a thumb-slide, a push-button, a rotating lever, or other mechanical structure for providing a movable coupling to the elongate body 16 and/or the handle 94. Moreover, the actuator element 106 may be movably coupled to the handle 44 such that the actuator element is movable into individual, distinct positions, and is able to be releasably secured in any one of the distinct positions.
The medical device 12 may include one or more rotational control elements 108 that are rotatably coupled to the proximal portion of the elongate body 16 and/or the handle 44. The rotational control element(s) 58 may further be coupled to the proximal and/or distal ends of the fluid delivery conduit 22, rod 50,68, selectors 76,86, or other fluid flow control elements described herein such that rotating the rotational control element 108 about a longitudinal axis of the handle 44 and/or elongate body 16 results in similar rotation of the attached component(s) at the distal portion of the medical device 12. The rotational control element 108 may include a knob, dial, or other mechanical structure for providing a rotatable coupling to the elongate body 16 and/or the handle 94. Moreover, the rotational control element 108 may be rotatably coupled to the handle 94 and/or elongate body 16 such that the rotational control element is movable into individual, distinct positions, and is able to be releasably secured in any one of the distinct positions.
The system 10 may further include one or more sensors to monitor the operating parameters throughout the system, including for example, pressure, temperature, flow rates, volume, or the like in the control unit 14 and/or the medical device 12, in addition to monitoring, recording or otherwise conveying measurements or conditions within the medical device 12 or the ambient environment at the distal portion of the medical device 12. The sensor(s) may be in communication with the control unit 14 for initiating or triggering one or more alerts or therapeutic delivery modifications during operation of the medical device 12. One or more valves, controllers, or the other components described herein may be in communication with the sensor(s) to provide for the automated and/or controlled dispersion or circulation of fluid through the lumens/fluid paths of the medical device 12. Such valves, controllers, or the like may be located in a portion of the medical device 12 and/or in the control unit 14.
In an exemplary system, a fluid supply 110 including a coolant, cryogenic refrigerant, or the like, an exhaust or scavenging system (not shown) for recovering or venting expended fluid for re-use or disposal, as well as various control mechanisms for the medical system may be housed in the control unit 14. In addition to providing an exhaust function for the catheter fluid supply, the control unit 14 may also include pumps, valves, controllers or the like to recover and/or re-circulate fluid delivered to the handle, the elongate body, and/or the fluid pathways of the medical device 12. A vacuum pump 112 in the control unit 14 may create a low-pressure environment in one or more conduits within the medical device 12 so that fluid is drawn into the conduit(s)/lumen(s) of the elongate body 16, away from the distal portion and towards the proximal portion of the elongate body 16. The control unit 14 may include one or more controllers, processors, and/or software modules containing instructions or algorithms to provide for the automated operation and performance of the features, sequences, or procedures described herein.
Several of the above configurations and methods of use thereof provide the ability to modify the effective cross-sectional area of the fluid delivery conduit available for fluid flow. Accordingly, selective control of these configurations allows fluid flow to be regulated as desired while the fluid delivery pressure remains the same. Additional configurations provided herein allow for the selective manipulation of a footprint or therapeutic pattern achievable with the medical device during a single procedure, negating the need for the removal and insertion of multiple devices to achieve the same variations in treatment geometry or characteristics. Moreover, while the medical device 12 may be in fluid communication with a cryogenic fluid source to cryogenically treat selected tissue, it is also contemplated that the medical device 12 may alternatively or additionally include one or more electrically conductive portions or electrodes thereon coupled to a radiofrequency generator or power source of the control unit 14 as a treatment or diagnostic mechanism.
It will be appreciated by persons skilled in the art that the present invention is not limited to what has been particularly shown and described herein above. In addition, unless mention was made above to the contrary, it should be noted that all of the accompanying drawings are not to scale. Of note, the system components have been represented where appropriate by conventional symbols in the drawings, showing only those specific details that are pertinent to understanding the embodiments of the present invention so as not to obscure the disclosure with details that will be readily apparent to those of ordinary skill in the art having the benefit of the description herein. Moreover, while certain embodiments or figures described herein may illustrate features not expressly indicated on other figures or embodiments, it is understood that the features and components of the system and devices disclosed herein are not necessarily exclusive of each other and may be included in a variety of different combinations or configurations without departing from the scope and spirit of the invention. A variety of modifications and variations are possible in light of the above teachings without departing from the scope and spirit of the invention, which is limited only by the following claims.
This application is a Divisional of U.S. Utility patent application Ser. No. 13/409,875, filed Mar. 1, 2012, entitled SYSTEMS AND METHODS FOR VARIABLE INJECTION FLOW which application is a Continuation of U.S. Utility patent application Ser. No. 13/300,931, filed Nov. 21, 2011, entitled SYSTEMS AND METHODS FOR VARIABLE INJECTION FLOW, which application is related to and claims priority to U.S. Provisional Application Ser. No. 61/552,527, filed Oct. 28, 2011, entitled SYSTEMS AND METHODS FOR VARIABLE INJECTION FLOW, the entirety of which is incorporated herein by reference.
Number | Name | Date | Kind |
---|---|---|---|
3903871 | Chisum et al. | Sep 1975 | A |
3938514 | Boucher | Feb 1976 | A |
4029099 | Fifield | Jun 1977 | A |
4176662 | Frazer | Dec 1979 | A |
4202336 | van Gerven | May 1980 | A |
4375220 | Matvias | Mar 1983 | A |
4411656 | Cornett, III | Oct 1983 | A |
4509370 | Hirschfeld | Apr 1985 | A |
4620769 | Tsuno | Nov 1986 | A |
4660571 | Hess et al. | Apr 1987 | A |
4664120 | Hess | May 1987 | A |
4686996 | Ulbrich | Aug 1987 | A |
4690155 | Hess | Sep 1987 | A |
4699147 | Chilson et al. | Oct 1987 | A |
4704104 | Christensen | Nov 1987 | A |
4709698 | Johnston et al. | Dec 1987 | A |
4725267 | Vaillancourt | Feb 1988 | A |
4754752 | Ginsburg et al. | Jul 1988 | A |
4776349 | Nashef et al. | Oct 1988 | A |
4787882 | Claren | Nov 1988 | A |
4813425 | Malis | Mar 1989 | A |
4823790 | Alperovich et al. | Apr 1989 | A |
4850351 | Herman et al. | Jul 1989 | A |
4945912 | Langberg | Aug 1990 | A |
4946440 | Hall | Aug 1990 | A |
4979948 | Geddes et al. | Dec 1990 | A |
4998933 | Eggers et al. | Mar 1991 | A |
5007437 | Sterzer | Apr 1991 | A |
5010894 | Edhag | Apr 1991 | A |
5015240 | Soproni et al. | May 1991 | A |
5078713 | Varney | Jan 1992 | A |
5100388 | Behl et al. | Mar 1992 | A |
5139496 | Hed | Aug 1992 | A |
5147355 | Friedman et al. | Sep 1992 | A |
5168880 | Sogawa et al. | Dec 1992 | A |
5205298 | Hurst | Apr 1993 | A |
5224943 | Goddard | Jul 1993 | A |
5228442 | Imran | Jul 1993 | A |
5231995 | Desai | Aug 1993 | A |
5281213 | Milder et al. | Jan 1994 | A |
5281215 | Milder | Jan 1994 | A |
5293869 | Edwards et al. | Mar 1994 | A |
5314408 | Salmon et al. | May 1994 | A |
5327881 | Greene | Jul 1994 | A |
5334181 | Rubinsky et al. | Aug 1994 | A |
5342295 | Imran | Aug 1994 | A |
5363882 | Chikama | Nov 1994 | A |
5364353 | Corfitsen et al. | Nov 1994 | A |
5380307 | Chee et al. | Jan 1995 | A |
5403309 | Coleman et al. | Apr 1995 | A |
5409469 | Schaerf | Apr 1995 | A |
5423807 | Milder | Jun 1995 | A |
5452582 | Longsworth | Sep 1995 | A |
5466222 | Ressemann et al. | Nov 1995 | A |
5487385 | Avitall | Jan 1996 | A |
5520682 | Baust et al. | May 1996 | A |
5545200 | West et al. | Aug 1996 | A |
5569161 | Ebling et al. | Oct 1996 | A |
5575773 | Song et al. | Nov 1996 | A |
5624392 | Saab | Apr 1997 | A |
5669870 | Elist | Sep 1997 | A |
5766192 | Zacca | Jun 1998 | A |
5769702 | Hanson | Jun 1998 | A |
5792105 | Lin et al. | Aug 1998 | A |
5792118 | Kurth et al. | Aug 1998 | A |
5797879 | DeCampli | Aug 1998 | A |
5800482 | Pomeranz et al. | Sep 1998 | A |
5810802 | Panescu et al. | Sep 1998 | A |
5876324 | Trouchine | Mar 1999 | A |
5957963 | Dobak, III | Sep 1999 | A |
6001117 | Huxel et al. | Dec 1999 | A |
6004269 | Crowley et al. | Dec 1999 | A |
6033426 | Kaji | Mar 2000 | A |
6096068 | Dobak, III et al. | Aug 2000 | A |
6106518 | Wittenberger et al. | Aug 2000 | A |
6149677 | Dobak, III | Nov 2000 | A |
6162171 | Ng et al. | Dec 2000 | A |
6190348 | Tiemann et al. | Feb 2001 | B1 |
6224624 | Lasheras et al. | May 2001 | B1 |
6235019 | Lehmann et al. | May 2001 | B1 |
6238371 | Himbert et al. | May 2001 | B1 |
6238428 | Werneth et al. | May 2001 | B1 |
6245095 | Dobak, III et al. | Jun 2001 | B1 |
6248089 | Porat | Jun 2001 | B1 |
6248096 | Dwork et al. | Jun 2001 | B1 |
6251130 | Dobak, III et al. | Jun 2001 | B1 |
6254626 | Dobak, III et al. | Jul 2001 | B1 |
6270482 | Rosoff et al. | Aug 2001 | B1 |
6270488 | Johnson et al. | Aug 2001 | B1 |
6283294 | Thorball et al. | Sep 2001 | B1 |
6312452 | Dobak, III et al. | Nov 2001 | B1 |
6315761 | Shcherbina et al. | Nov 2001 | B1 |
6319235 | Yoshino | Nov 2001 | B1 |
6319248 | Nahon | Nov 2001 | B1 |
7041080 | Dion | May 2006 | B2 |
7282041 | Igarashi et al. | Oct 2007 | B2 |
20010001830 | Dobak, III et al. | May 2001 | A1 |
20010001831 | Dobak, III et al. | May 2001 | A1 |
20010002442 | Dobak, III et al. | May 2001 | A1 |
20010011184 | Dobak, III et al. | Aug 2001 | A1 |
20010011185 | Dobak, III et al. | Aug 2001 | A1 |
20010016763 | Lasheras et al. | Aug 2001 | A1 |
20010021865 | Dobak, III et al. | Sep 2001 | A1 |
20010021866 | Dobak, III et al. | Sep 2001 | A1 |
20010029394 | Dobak, III et al. | Oct 2001 | A1 |
20010047138 | Kokate et al. | Nov 2001 | A1 |
20020062122 | Lehmann et al. | May 2002 | A1 |
20020193751 | Theeuwes et al. | Dec 2002 | A1 |
20040249349 | Wentling | Dec 2004 | A1 |
20050027246 | Dion | Feb 2005 | A1 |
20090112156 | Rush et al. | Apr 2009 | A1 |
20090234345 | Hon | Sep 2009 | A1 |
20110184398 | Desrochers | Jul 2011 | A1 |
Number | Date | Country |
---|---|---|
2041519 | Jul 2002 | CA |
4331198 | Mar 1994 | DE |
0455478 | Nov 1991 | EP |
0810003 | Dec 1997 | EP |
002163655 | Mar 1986 | GB |
402095364 | Apr 1990 | JP |
405293077 | Nov 1993 | JP |
9407549 | Apr 1994 | WO |
WO9171878 | Apr 1998 | WO |
2004009171 | Jan 2004 | WO |
Entry |
---|
EPO, PCT/US2012/060761, Feb. 1, 2013 Invitation to Pay Additional Fees and Partial International search Report, pp. 1-8. |
EPO, PCT/US2012/060761, Apr. 10, 2013 International Search Report, pp. 1-7. |
EPO, PCT/US2012/060761, Apr. 10, 2013 Written Opinion of the International Searching Authority, pp. 1-12. |
Number | Date | Country | |
---|---|---|---|
20160206360 A1 | Jul 2016 | US |
Number | Date | Country | |
---|---|---|---|
61552527 | Oct 2011 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 13409875 | Mar 2012 | US |
Child | 15081373 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 13300931 | Nov 2011 | US |
Child | 13409875 | US |